LabGenomics Co. Ltd (084650) — Cash Flow-to-Debt Ratio
LabGenomics Co. Ltd (084650) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of ₩-6.41 Billion could theoretically repay 0% of its total liabilities (₩76.00 Billion) in one year. See how much free cash does LabGenomics Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
LabGenomics Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for LabGenomics Co. Ltd across 11 annual periods. Also explore 084650 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for LabGenomics Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for LabGenomics Co. Ltd. For market capitalisation and broader financial context, see LabGenomics Co. Ltd (084650) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.16x | ₩-12.99 Billion | ₩79.35 Billion | ▼ -676.9% |
| 2023 | 0.03x | ₩2.42 Billion | ₩85.31 Billion | ▼ -98.3% |
| 2022 | 1.69x | ₩69.87 Billion | ₩41.32 Billion | ▲ +20.5% |
| 2021 | 1.40x | ₩65.36 Billion | ₩46.57 Billion | ▼ -15.8% |
| 2020 | 1.67x | ₩46.37 Billion | ₩27.82 Billion | ▲ +896.5% |
| 2019 | 0.17x | ₩3.19 Billion | ₩19.06 Billion | ▲ +367.4% |
| 2018 | 0.04x | ₩608.03 Million | ₩16.99 Billion | ▲ +159.3% |
| 2017 | -0.06x | ₩-1.06 Billion | ₩17.52 Billion | ▼ -143.1% |
| 2016 | 0.14x | ₩2.54 Billion | ₩18.17 Billion | ▼ -43.9% |
| 2015 | 0.25x | ₩2.38 Billion | ₩9.54 Billion | ▼ -21.9% |
| 2014 | 0.32x | ₩3.15 Billion | ₩9.86 Billion | — |